Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
The aim of the action is to complement the implementation of the ‘Joint Action on Personalized Cancer Medicine’ led by the Member States, thus helping to reduce the burden of cancer both at a personal and societal level, namely by supporting the Europe’s Beating Cancer Plan and policy initiatives on personalised medicine. It may also support other Union initiatives that aim at improving public health, such as the ‘1+ Million Genomes’ Initiative and the Initiative to Understand Cancer (UNCAN.eu) in so far as it shares the objectives of promoting personalised treatments and support ground-breaking research needed to advance the understanding of cancer mechanisms in order to improve the cancer care pathway.
Detailed Call Description
This action should cover the ambition of the sixth flagship of the Europe’s Beating Cancer Plan, the ‘Cancer diagnostic and treatment for all’ initiative. It will build on the results of the EU4Health Programme funded projects, such as the Personalised Cancer Medicine for all EU citizens (‘PCM4EU’), the EU Cancer and Public Health Genomics platform project (‘CAN.HEAL’), as well as the project for improved diagnostics and survival for all children with Acute Myeloid and the Leukaemia treated within the NOPHO-DB- SHIP consortium; a cross-European collaboration (‘CHIP-AML22’). The action will also make use of the guidelines, protocols and best practices, developed under other European Commission funded initiatives and projects such as the 1+ Million Genomes Initiative, a European-wide foundation to accelerate Data-driven Cancer Research (EOSC4Cancer), and Partnership on Transforming Health and Care Systems (THCS) as well as Innovative Health Initiative (IHI)funded projects could also be considered.
Activities will contribute to the Joint Action on Personalized Cancer Medicine’, and include:
- the implementation of targeted projects involving civil society organisations and industry complementing the Member States’ efforts in the design, planning and implementation of best practices (e.g., on metastatic cancer);
- the production of public health guidelines concerning personalised cancer medicine, genomic testing/screening and metastatic cancer management;
- patients and caregivers consultations, and other actions that can benefit citizens directly;
- preparation and roll out of innovative practices;
- support capacity building actions such as training and twinning, health communication or health literacy.
Activities should also include an equity dimension and aim at reducing health inequalities.
Call Total Budget
Thematic Categories
- Education and training
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Associations
- Educational Institutions
- Local Authorities
- NGOs
- Non Profit Organisations
- Other Beneficiaries
- Researchers/Research Centers/Institutions
- State-owned Enterprises
Eligibility For Participation Notes
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies)
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories (OCTs)
- eligible non-EU countries: listed EEA countries and countries associated to the EU4Health Programme (list of participating countries)
Other eligibility conditions:
- academia and education establishments
- research institutes
- hospitals
- public authorities
- expert networks
- civil society organisations
- associations
- foundations
- NGOs and similar entities
Consortium composition:
- Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions:
- minimum 3 independent entities from 3 different eligible countries are foreseen for the topics.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
Email: emakrigiorgi@moh.gov.cy
EU Contact Point
For help related to this call, please contact: hadea-hp-calls@ec.europa.eu